Bruce Kent Winner, MD | |
680 W Columbia Ave, Battle Creek, MI 49015-3028 | |
(269) 965-4500 | |
(269) 965-1150 |
Full Name | Bruce Kent Winner |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 680 W Columbia Ave, Battle Creek, Michigan |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285734459 | NPI | - | NPPES |
1285734459 | Medicaid | MI | |
700C910950 | Other | MI | BCBSM |
080101081 | Other | MI | RAILROAD MEDICARE |
BW057232 | Other | MI | BCNBC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | BW057232 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Bruce Kent Winner, MD 601 John St, Box 42, Kalamazoo, MI 49007-5341 Ph: (269) 341-7806 | Bruce Kent Winner, MD 680 W Columbia Ave, Battle Creek, MI 49015-3028 Ph: (269) 965-4500 |
News Archive
For some women, digital mammography may be a better screening option than film mammography, according to newly published results from a national study led by a University of North Carolina at Chapel Hill researcher.
States around the nation are grappling with Medicaid issues ranging from expanding coverage and making deals with new managed care providers to sharing insurer rebates, forging budget cuts, waiting on court action and admitting large data breaches.
Array BioPharma Inc. today announced results from a randomized Phase 2 placebo-controlled study conducted by AstraZeneca comparing the efficacy of selumetinib in combination with docetaxel with docetaxel alone in the second-line treatment of 87 patients prospectively selected with KRAS-mutant, locally advanced or metastatic non-small cell lung cancer.
Although the current practice of analysing defined gene panels for a specific disease has great utility, it is of limited benefit when a condition is not well defined.
Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company, today announced that it has resubmitted to the U.S. Food and Drug Administration the New Drug Application ("NDA") for its investigational candidate, YOSPRALA (PA32540/PA8140) for the secondary prevention of cardiovascular disease in patients at risk for aspirin-induced gastric ulcers.
› Verified 1 days ago
Zachary Young, DO General Practice Medicare: Medicare Enrolled Practice Location: 7175 Tower Rd Ste E, Battle Creek, MI 49014 Phone: 269-719-2498 Fax: 269-719-2239 | |
Stephanie T Bui, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 363 Fremont St, Suite 101, Battle Creek, MI 49017 Phone: 269-245-8350 Fax: 269-245-8305 | |
Jillian Gecewicz, PA-C General Practice Medicare: Not Enrolled in Medicare Practice Location: 5500 Armstrong Rd, Battle Creek, MI 49037 Phone: 269-966-5600 |